CLM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Clearside Biomedical Inc

Watchlist Manager

Watchlist

Price: 4.11 EUR Market Closed

Market Cap: €256.5m

C	Clearside Biomedical Inc DUS:CLM	US
	Freeport-McMoRan Inc NYSE:FCX	US
	Baidu Inc F:B1CB	CN
B	BP PLC XBER:BPE5	UK
I	International Consolidated Airlines Group SA XMUN:INR	UK

Profitability Summary

Clearside Biomedical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

86%

Negative Operating Margin

-525%

Negative 3Y Average Operating Margin

-1 049%

Operating Margin is Increasing

-3 084% > -525%

Negative Net Margin

-665%

Negative 3Y Average Net Margin

-1 265%

Net Margin is Increasing

-3 529% > -665%

Negative Free Cash Flow Margin

-534%

Negative 3Y Average Free Cash Flow Margin

-901%

Free Cash Flow Margin is Increasing

-2 534% > -534%

Exceptional ROE

72%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-1 453%

ROIC is Increasing

-3 022% > -573%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.